Product Images Imatinib Mesylate

This is a description of Imatinib Mesylate Tablets, which come in a pack of 30 tablets. Each tablet contains the equivalent of 100mg of Imatinib. This medicine is prescription-only, and full prescribing information can be found in the package insert. It should be stored at 20-25°C and protected from moisture. This drug should be kept out of reach of children, and should not be used if the blister is torn or broken. The manufacturer is Sun Pharmaceutical Industries, and the tablets are distributed by American Health Packaging.*

This is a package of Imatinib Mesylate Tablets with NDC code 60687-203-25. It contains 30 tablets (5 x 6) with a strength of 400 mg of imatinib free base per tablet. The usual dosage information can be found in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). The drug is from NDC# 47335-475, Sun Pharmaceutical Industries, Inc. This drug is distributed by American Health Packaging in Columbus, Ohio. The product should be kept out of reach of children and should not be used if the blister is torn or broken.*

This is a statistical data about patients with a medical condition, comparing the effects of Imatinib Mesylate and 1FN+Ara-C therapies. The data shows the number of patients with progression and censored at discontinuation or last follow-up. The Hazard Ratio is 0.378 with a 95% C1 confidence interval of [0.291, 0.493]. The Log-rank Test P-value is less than 0.0001. The time frame considered is in months since randomization.*

This is a statistical table that details the results of a study involving Imatinib Mesylate and FN+Ara-C for patients who progress to AP or BC without PD to AP/BC. The table shows the number of patients, censoring, hazard ratio, and log-rank test. The data is presented in two arms: the Imatinib Mesylate arm and the FN+Ara-C arm. The number of months since randomization is also provided.*